• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION MAXZERO NEEDLELESS CONNECTOR; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION MAXZERO NEEDLELESS CONNECTOR; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number MZ1000-07
Device Problems Partial Blockage (1065); Obstruction of Flow (2423)
Patient Problem No Code Available (3191)
Event Type  malfunction  
Manufacturer Narrative
Concomitant medical products: picc line (1.9 french); event occurred may, 2019.Specific date not available.(b)(4).The affected product has been received and the investigation is pending.A follow up report will be submitted with investigation results once the evaluation has been completed.Although requested, patient demographic details and laboratory/test details and pre-existing medical conditions were not provided.The patient is an infant.
 
Event Description
It was reported that an occlusion occurred in the nicu for an infant receiving tpn and lipids at low rates via two different pumps and a peripherally inserted central catheter (picc line).The pumps alarmed for occlusion, and user troubleshooting determined that the picc was occluded.Tpa was administered to restore patency.Patency continued until the following day when the line occluded again and the picc line was removed and replaced.No other effect to the infant was reported.The patient's infusion set up was a 1.9 french picc line attached to the needleless connector which was attached to the bifuse which had two needleless connectors at the extension ends.The event reporter did not have exact details, and stated typically the extensions had tpn (typically 7-10 ml/hr) and lipids (typically 0.4 ml/hr) infusing.The connector on the patient's picc line was not sequestered, however the bifuse set was saved.Clinicians utilize chlorhexidine to cleanse needleless connection points prior to attaching the tubing or flushing.The nurse educator stated that occlusions had occurred with four patients.This file is for one event.She also stated that occlusions had not reoccurred after changing the procedure whereby the needleless connector attached directly to the picc line was removed and the bifuse male luer connected directly to the hub of the picc line.
 
Manufacturer Narrative
The customer¿s report of an occlusion was not confirmed.Visual inspection of the concomitant set noted no damage or any anomalies.Functional and pressure testing resulted in the set flowing freely and showed no signs of occlusion from each port.The root cause of the customer¿s report of occlusion was not identified.The suspect max-zero set was not returned for investigation.
 
Event Description
It was reported that an occlusion occurred in the nicu for an infant receiving tpn and lipids at low rates via two different pumps and a peripherally inserted central catheter (picc line).The pumps alarmed for occlusion, and user troubleshooting determined that the picc was occluded.Tpa was administered to restore patency.Patency continued until the following day when the line occluded again and the picc line was removed and replaced.No other effect to the infant was reported.The patient's infusion set up was a 1.9 french picc line attached to the needleless connector which was attached to the bifuse which had two needleless connectors at the extension ends.The event reporter did not have exact details, and stated typically the extensions had tpn (typically 7-10 ml/hr) and lipids (typically 0.4 ml/hr) infusing.The connector on the patient's picc line was not sequestered, however the bifuse set was saved.Clinicians utilize chlorhexidine to cleanse needleless connection points prior to attaching the tubing or flushing.The nurse educator stated that occlusions had occurred with four patients.This file is for one event.She also stated that occlusions had not reoccurred after changing the procedure whereby the needleless connector attached directly to the picc line was removed and the bifuse male luer connected directly to the hub of the picc line.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAXZERO NEEDLELESS CONNECTOR
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key8741831
MDR Text Key149506766
Report Number9616066-2019-01788
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10885403240775
UDI-Public10885403240775
Combination Product (y/n)N
PMA/PMN Number
K132413
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 05/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMZ1000-07
Device Catalogue NumberMZ1000-07
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/06/2019
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/27/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
8100,MZ1000,PRI TUBING,8015, TD UNK; MZ9265
Patient Outcome(s) Required Intervention;
-
-